A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2001
11/15/2001	US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001	US20010041171 Polymer with pendant acid functional groups; will not degrade in the gastrointestinal tract
11/15/2001	CA2776904A1 A device for forming or increasing the number of undifferentiated cells
11/15/2001	CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	CA2408738A1 Virulence genes, proteins, and their use
11/15/2001	CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	CA2408453A1 Uridine derivatives as antibiotics
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408236A1 Peptide deformylase inhibitors
11/15/2001	CA2408234A1 Peptide deformylase inhibitors
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407897A1 Molecular antigen arrays and vaccines
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001	CA2407697A1 Felbamate derived compounds
11/15/2001	CA2406644A1 Sentinel virus ii
11/15/2001	CA2406633A1 Anti-viral pyrimidine nucleoside analogues
11/15/2001	CA2403264A1 Chiral fluoroquinolizinone arginine salt forms
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153924A2 Substituted 1,3-oxathiolanes with antiviral properties
11/14/2001	EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001	EP1153620A2 Solid compositions exhibiting selective binding to dissolved iron
11/14/2001	EP1153610A1 Matrix protein compositions for inflammatory and infectious conditions
11/14/2001	EP1153546A1 Novel use of delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite
11/14/2001	EP1153129A1 Method of treating restenosis by antisense targeting of c-myc
11/14/2001	EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001	EP1153014A2 Beta-alanine derivatives
11/14/2001	EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001	EP1152769A1 Yeast cell wall peptides and antibodies thereto
11/14/2001	EP1152768A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
11/14/2001	EP1152765A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
11/14/2001	EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001	EP1152750A1 Spontaneously dispersible n-benzoyl staurosporine compositions
11/14/2001	EP1003537B1 Composition comprising propolis and at least an essential oil
11/14/2001	EP0956016A4 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
11/14/2001	EP0862431B1 Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate
11/14/2001	EP0850246B1 Pyrimidine nucleoside derivatives
11/14/2001	EP0847400B1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
11/14/2001	EP0828721B1 2-amino-benzoxazinones for the treatment of viral infections
11/14/2001	EP0728763B1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor
11/14/2001	EP0713527B1 Fungicidal methods and compositions for killing yeast and sporular microorganisms
11/14/2001	EP0576471B1 Recombinant virus vectors encoding human papillomavirus proteins
11/14/2001	CN1322251A Mutant human hepatitis B viral strain and uses thepeof
11/14/2001	CN1322250A Peptides derived from attachment (G) protein of respiratory syncytial virus
11/14/2001	CN1322249A Neiseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/14/2001	CN1322214A Induction of antiobiotic proteins and peptides by LAIT/sCD14-protein
11/14/2001	CN1322207A Process for preparation of 3-sulfonyloxy-3-cephem compounds
11/14/2001	CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001	CN1322203A Heterocyclyl amino methyloxazolidinones as antibacterials
11/14/2001	CN1322202A Quinazoline derivatives
11/14/2001	CN1322198A HIV replication inhibiting pyrimidines
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1322188A A process for preparation of 4,4'-dihalogen-O-hydroxydiphenyl compounds
11/14/2001	CN1322109A Hydroxystilbene compounds used as microbicidal active substances
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321638A Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol
11/14/2001	CN1321513A Medicine and food dual-purpose enriched nutrient for resisting AIDS
11/14/2001	CN1321481A Medicine for external application for treating sweaty feet with bromidrosis
11/14/2001	CN1321475A Chinese medicine gel powder
11/14/2001	CN1321472A Medicinal tea for curing bacillary dysentery and its preparation method
11/14/2001	CN1321470A Method for preparing genetic antibiotic peptide medicine for animals from transgenic antibiotic peptide muscidian vermicule and its application
11/14/2001	CN1074767C Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
11/14/2001	CN1074675C Chinese medicine composition for producing domestic chemical product
11/13/2001	US6316618 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives
11/13/2001	US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001	US6316496 For therapy of retroviral infection; prophylaxis of replication of retrovirus, therapy of aids (acquired immune deficiency syndrome)
11/13/2001	US6316495 Administering 5-iodo-6-amino-1,2-benzopyrones for inhibiting the poly-adp-ribosylation of adenosine diphosphoribosyl transferase
11/13/2001	US6316492 Methods for treating or preventing viral infections and associated diseases
11/13/2001	US6316488 Antibiotic compound
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors
11/13/2001	US6316464 P38 MAP kinase inhibitors
11/13/2001	US6316456 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
11/13/2001	US6316433 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/13/2001	US6316424 Sulfated phosphatidylinositols, their preparation and use of the same
11/13/2001	US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors
11/13/2001	US6316405 Cyclosporin a conjugates and uses therefor
11/13/2001	US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316237 Respiratory nitrate reductase alpha subunit
11/13/2001	US6316005 Borrelia burgdorferi bacterin
11/13/2001	US6316002 Germination activated red Ganoderma lucidum spores and method for producing the same
11/12/2001	CA2347566A1 Solid compositions exhibiting selective binding to dissolved iron
11/08/2001	WO2001083794A2 Dna transfection system for the generation of infectious influenza virus
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083774A2 Novel mutated form of arginine deiminase
11/08/2001	WO2001083755A2 Human anti-cd40 antibodies and methods of making and using same
11/08/2001	WO2001083754A2 Cellular regulators of infectious agents and methods of use
11/08/2001	WO2001083747A2 Prion proteins and their uses
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083561A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses

1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 1798